Invus Global Management, LLC - 16 Oct 2025 SCHEDULE 13G Report for Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value (RANI)

Filing Manager
Invus Global Management, LLC
Reporting Manager
Raymond Debbane
Security
Rani Therapeutics Holdings, Inc. Class A Common Stock, $0.0001 par value
Symbol
RANI
Shares outstanding
98,357,467 shares
Disclosed Ownership
9,825,911 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
23 Oct 2025, 17:05:17 UTC
Date of event
16 Oct 2025
SEC
View on sec.gov

Reporting Managers (8)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Invus Public Equities, L.P. 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner
Invus Public Equities Advisors, LLC 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Invus Global Management, LLC 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Siren, L.L.C. 8.8% 8,617,378 8,617,378 0 /s/ Raymond Debbane Raymond Debbane, President
Avicenna Life Sci Master Fund LP 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner
Avicenna Life Sci Master GP LLC 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, Chief Executive Officer
Ulys, L.L.C. 1.3% 1,208,533 1,208,533 0 /s/ Raymond Debbane Raymond Debbane, President
Raymond Debbane 10% 9,825,911 9,825,911 0 /s/ Raymond Debbane Raymond Debbane